Stocks and Investing
by (remove) : Francois Brisebois
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Francois Brisebois
RSSJSONXMLCSV
Mon, August 26, 2024
Thu, August 15, 2024
Fri, August 9, 2024
Wed, June 26, 2024
Tue, June 25, 2024
Thu, June 13, 2024
Tue, May 21, 2024
Mon, May 13, 2024
Thu, May 9, 2024
Mon, May 6, 2024
Wed, April 3, 2024
Mon, April 1, 2024
Tue, March 5, 2024
Wed, February 28, 2024
Tue, December 12, 2023
Fri, July 7, 2023
Fri, June 30, 2023
Wed, June 21, 2023
Mon, June 12, 2023
Mon, May 8, 2023
Tue, May 2, 2023
Thu, April 6, 2023
Mon, April 3, 2023
Fri, March 17, 2023
Mon, February 27, 2023
Mon, February 6, 2023
Mon, October 3, 2022
Wed, September 7, 2022
Mon, July 18, 2022
Tue, November 23, 2021

Francois Brisebois Reiterated (TRDA) at Buy and Held Target at $25 on, Aug 26th, 2024


Published on 2024-10-28 13:53:51 - WOPRAI, Francois Brisebois
  Print publication without navigation


Francois Brisebois of Oppenheimer, Reiterated "Entrada Therapeutics, Inc." (TRDA) at Buy and Held Target at $25 on, Aug 26th, 2024.

Francois has made no other calls on TRDA in the last 4 months.



There is 1 other peer that has a rating on TRDA. Out of the 1 peers that are also analyzing TRDA, 0 agree with Francois's Rating of Hold.



This is the rating of the analyst that currently disagrees with Francois


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $18 on, Wednesday, August 14th, 2024
Contributing Sources